Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity

Daniel P. Walker, Michael P. Zawistoski, Molly A. McGlynn, Jiancheng Li, Daniel W. Kung, Peter C. Bonnette, Amy Baumann, Leonard Buckbinder, Janet A. Houser, Jason Boer,

Bioorganic & Medicinal Chemistry Letters · 2009 · 88 citations · 19 references

DOIFull text

Open access

Concepts

References

19